Cas 636574-07-7,1H-Benzimidazole-4-carboxamide, 2-[[[4-[(1-oxopropyl)amino]phenyl]thio]methyl]-

636574-07-7

Post Buying Request

Basic information

Product Name: 1H-Benzimidazole-4-carboxamide, 2-[[[4-[(1-oxopropyl)amino]phenyl]thio]methyl]-
Synonyms:
CAS NO:636574-07-7
Molecular Formula: C18H18N4O2S
Molecular Weight: 354.433
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 1H-Benzimidazole-4-carboxamide, 2-[[[4-[(1-oxopropyl)amino]phenyl]thio]methyl]-(CAS DataBase Reference)
NIST Chemistry Reference: 1H-Benzimidazole-4-carboxamide, 2-[[[4-[(1-oxopropyl)amino]phenyl]thio]methyl]-(636574-07-7)
EPA Substance Registry System: 1H-Benzimidazole-4-carboxamide, 2-[[[4-[(1-oxopropyl)amino]phenyl]thio]methyl]-(636574-07-7)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 636574-07-7(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

636574-07-7 Suppliers

Recommended suppliers

636574-07-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 636574-07-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,3,6,5,7 and 4 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 636574-07:
(8*6)+(7*3)+(6*6)+(5*5)+(4*7)+(3*4)+(2*0)+(1*7)=177
177 % 10 = 7
So 636574-07-7 is a valid CAS Registry Number.

636574-07-7Upstream product

636574-07-7Downstream Products

636574-07-7Relevant academic research and scientific papers

BENZIMIDAZOLE INHIBITORS OF POLY(ADP-RIBOSYL) POLYMERASE

-

Page 39, (2010/02/05)

Compounds of formula I are poly(ADP-ribosyl)transferase (PARP) inhibitors, and are useful as therapeutics in treatment of cancers and the amelioration of the effects of stroke, head trauma, and neurodegenerative disease. As cancer therapeutics, the compounds of the 5 invention may be used in combination with cytotoxic agents and/or radiation.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 636574-07-7